BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27064994)

  • 1. Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012.
    Park LS; Tate JP; Sigel K; Rimland D; Crothers K; Gibert C; Rodriguez-Barradas MC; Goetz MB; Bedimo RJ; Brown ST; Justice AC; Dubrow R
    AIDS; 2016 Jul; 30(11):1795-806. PubMed ID: 27064994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study.
    Park LS; Tate JP; Sigel K; Brown ST; Crothers K; Gibert C; Goetz MB; Rimland D; Rodriguez-Barradas MC; Bedimo RJ; Justice AC; Dubrow R
    Ann Intern Med; 2018 Jul; 169(2):87-96. PubMed ID: 29893768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
    Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
    Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.
    Krishnan S; Schouten JT; Jacobson DL; Benson CA; Collier AC; Koletar SL; Santana J; Sattler FR; Mitsuyasu R;
    Oncology; 2011; 80(1-2):42-9. PubMed ID: 21606663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and the risk of cancers with and without a known infectious cause.
    Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
    AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.
    Crum-Cianflone NF; Wang X; Ganesan A; Okulicz J; Weintrob A; Lalani T; Agan B
    AIDS Res Hum Retroviruses; 2015 May; 31(5):514-8. PubMed ID: 25417712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.
    Long JL; Engels EA; Moore RD; Gebo KA
    AIDS; 2008 Feb; 22(4):489-96. PubMed ID: 18301061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence in people living with HIV/AIDS in Israel, 1981-2010.
    Zohar M; Micha B
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):873-81. PubMed ID: 25941873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.
    Althoff KN; McGinnis KA; Wyatt CM; Freiberg MS; Gilbert C; Oursler KK; Rimland D; Rodriguez-Barradas MC; Dubrow R; Park LS; Skanderson M; Shiels MS; Gange SJ; Gebo KA; Justice AC;
    Clin Infect Dis; 2015 Feb; 60(4):627-38. PubMed ID: 25362204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
    Silverberg MJ; Lau B; Achenbach CJ; Jing Y; Althoff KN; D'Souza G; Engels EA; Hessol NA; Brooks JT; Burchell AN; Gill MJ; Goedert JJ; Hogg R; Horberg MA; Kirk GD; Kitahata MM; Korthuis PT; Mathews WC; Mayor A; Modur SP; Napravnik S; Novak RM; Patel P; Rachlis AR; Sterling TR; Willig JH; Justice AC; Moore RD; Dubrow R;
    Ann Intern Med; 2015 Oct; 163(7):507-18. PubMed ID: 26436616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.
    Crothers K; Huang L; Goulet JL; Goetz MB; Brown ST; Rodriguez-Barradas MC; Oursler KK; Rimland D; Gibert CL; Butt AA; Justice AC
    Am J Respir Crit Care Med; 2011 Feb; 183(3):388-95. PubMed ID: 20851926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
    Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; De Wit S; Phillips A; Lundgren JD; Sabin CA;
    BMC Infect Dis; 2013 Oct; 13():471. PubMed ID: 24106926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
    Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
    Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and trend of AIDS-defining cancers and non-AIDS-defining cancers and their association with antiretroviral therapy among people living with HIV in South Carolina: a population-based cohort study.
    Nkwonta CA; Zhang J; Chen S; Weissman S; Olatosi B; Li X
    AIDS Care; 2023 May; 35(5):753-763. PubMed ID: 35578401
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer in HIV-infected persons from the Caribbean, Central and South America.
    Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
    Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
    Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
    Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
    Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
    J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer burden in the HIV-infected population in the United States.
    Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
    J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
    Bedimo RJ; McGinnis KA; Dunlap M; Rodriguez-Barradas MC; Justice AC
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):203-8. PubMed ID: 19617846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.